The inhibition of FAAH, the key enzyme responsible for the deactivation of this fatty acid, could therefore offer a treatment strategy for several neuropsychiatric and neurological diseases, including chronic pain, inflammation, neurodegeneration, depression, anxiety [11,44,45]. This evidence concerns the gene FAAH and depressive symptom measurement.